Literature DB >> 25253288

Killer immunoglobulin-like receptor gene repertoire influences viral load of primary human cytomegalovirus infection in renal transplant patients.

D C Jones1, S Peacock2, D Hughes3, J A Traherne1, R L Allen4, M C N M Barnardo5, P Friend6, C J Taylor2, S Fuggle5, J Trowsdale1, N T Young7.   

Abstract

Killer cell immunoglobulin-like receptors (KIR) are highly polymorphic members of the immunoglobulin superfamily, which influence the response of natural killer cells and some T-lymphocyte subsets. Analysis of a cohort of previously human cytomegalovirus (HCMV)-negative patients, who developed primary HCMV infection following HCMV-positive renal transplant (n=76), revealed an increase in the frequency of KIR genes located on the telomeric region of B haplotypes (Tel B). The presence of Tel B in combination with the KIR ligand HLA-C2 was significantly more frequent in this subgroup. These genetic factors were associated with resistance to HCMV infection in a second cohort (n=65), where the Tel B genes KIR2DL5, -2DS1, 2DS5 and -3DS1 were all significantly associated with high viral loads. Furthermore, the KIR haplotype Tel A when in combination with the KIR ligand HLA-C1 was significantly protective against the development of severe infection. Our results suggest that KIR are a significant factor in the control of primary HCMV infection, and that determination of KIR gene repertoire may help in detection of renal transplant patients who were most at risk.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25253288     DOI: 10.1038/gene.2014.53

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  45 in total

1.  Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.

Authors:  K Hadaya; C de Rham; C Bandelier; C Bandelier; S Ferrari-Lacraz; S Jendly; T Berney; L Buhler; L Kaiser; J D Seebach; J M Tiercy; P Y Martin; J Villard
Journal:  Am J Transplant       Date:  2008-12       Impact factor: 8.086

2.  KIR2DL5, a novel killer-cell receptor with a D0-D2 configuration of Ig-like domains.

Authors:  C Vilches; R Rajalingam; M Uhrberg; C M Gardiner; N T Young; P Parham
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

3.  Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.

Authors:  Sarah Cooley; Daniel J Weisdorf; Lisbeth A Guethlein; John P Klein; Tao Wang; Chap T Le; Steven G E Marsh; Daniel Geraghty; Stephen Spellman; Michael D Haagenson; Martha Ladner; Elizabeth Trachtenberg; Peter Parham; Jeffrey S Miller
Journal:  Blood       Date:  2010-06-25       Impact factor: 22.113

4.  Human diversity in killer cell inhibitory receptor genes.

Authors:  M Uhrberg; N M Valiante; B P Shum; H G Shilling; K Lienert-Weidenbach; B Corliss; D Tyan; L L Lanier; P Parham
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

5.  A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey.

Authors:  L D Maxwell; A Wallace; D Middleton; M D Curran
Journal:  Tissue Antigens       Date:  2002-09

6.  The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients.

Authors:  M Stern; H Elsässer; G Hönger; J Steiger; S Schaub; C Hess
Journal:  Am J Transplant       Date:  2008-04-29       Impact factor: 8.086

7.  Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B.

Authors:  Natalia Gómez-Lozano; Clair M Gardiner; Peter Parham; Carlos Vilches
Journal:  Immunogenetics       Date:  2002-06-26       Impact factor: 2.846

8.  Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule.

Authors:  C J VandenBussche; T J Mulrooney; W R Frazier; S Dakshanamurthy; C K Hurley
Journal:  Genes Immun       Date:  2008-11-13       Impact factor: 2.676

Review 9.  Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection.

Authors:  M López-Botet; A Angulo; M Gumá
Journal:  Tissue Antigens       Date:  2004-03

10.  The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.

Authors:  J E Gumperz; V Litwin; J H Phillips; L L Lanier; P Parham
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more
  9 in total

1.  A Platform for Extracellular Interactome Discovery Identifies Novel Functional Binding Partners for the Immune Receptors B7-H3/CD276 and PVR/CD155.

Authors:  Bushra Husain; Sree R Ramani; Eugene Chiang; Isabelle Lehoux; Sairupa Paduchuri; Tia A Arena; Ashka Patel; Blair Wilson; Pamela Chan; Yvonne Franke; Athena W Wong; Jennie R Lill; Shannon J Turley; Lino C Gonzalez; Jane L Grogan; Nadia Martinez-Martin
Journal:  Mol Cell Proteomics       Date:  2019-07-15       Impact factor: 5.911

2.  Evaluation of telomeric KIR genes and their association with CMV infection in kidney transplant recipients.

Authors:  Negin Farzamikia; Seyyedeh Mina Hejazian; Mehdi Haghi; Seyyed Sina Hejazian; Sepideh Zununi Vahed; Mohammadreza Ardalan
Journal:  Immunogenetics       Date:  2022-01-29       Impact factor: 2.846

3.  LILRB1 polymorphisms influence posttransplant HCMV susceptibility and ligand interactions.

Authors:  Kang Yu; Chelsea L Davidson; Agnieszka Wójtowicz; Luiz Lisboa; Ting Wang; Adriana M Airo; Jean Villard; Jeremie Buratto; Tatyana Sandalova; Adnane Achour; Atul Humar; Katia Boggian; Alexia Cusini; Christian van Delden; Adrian Egli; Oriol Manuel; Nicolas Mueller; Pierre-Yves Bochud; Deborah N Burshtyn
Journal:  J Clin Invest       Date:  2018-03-12       Impact factor: 14.808

4.  Rapid reconstitution of CD4 T cells and NK cells protects against CMV-reactivation after allogeneic stem cell transplantation.

Authors:  Julia Drylewicz; Ingrid M M Schellens; Rogier Gaiser; Nening M Nanlohy; Esther D Quakkelaar; Henny Otten; Suzanne van Dorp; Ronald Jacobi; Leonie Ran; Sanne Spijkers; Dan Koning; Rob Schuurman; Ellen Meijer; Floortje L Pietersma; Jurgen Kuball; Debbie van Baarle
Journal:  J Transl Med       Date:  2016-08-02       Impact factor: 5.531

5.  Human Leukocyte Antigen C*12:02:02 and Killer Immunoglobulin-Like Receptor 2DL5 are Distinctly Associated with Ankylosing Spondylitis in the Taiwanese.

Authors:  Chin-Man Wang; Sheng-Hung Wang; Yeong-Jian Jan Wu; Jing-Chi Lin; Jianming Wu; Ji-Yih Chen
Journal:  Int J Mol Sci       Date:  2017-08-16       Impact factor: 5.923

Review 6.  Dual Role of Natural Killer Cells on Graft Rejection and Control of Cytomegalovirus Infection in Renal Transplantation.

Authors:  Miguel López-Botet; Carlos Vilches; Dolores Redondo-Pachón; Aura Muntasell; Aldi Pupuleku; José Yélamos; Julio Pascual; Marta Crespo
Journal:  Front Immunol       Date:  2017-02-16       Impact factor: 7.561

Review 7.  The Role of HLA and KIR Immunogenetics in BK Virus Infection after Kidney Transplantation.

Authors:  Marija Burek Kamenaric; Vanja Ivkovic; Ivana Kovacevic Vojtusek; Renata Zunec
Journal:  Viruses       Date:  2020-12-09       Impact factor: 5.048

Review 8.  HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation.

Authors:  Burcu Duygu; Timo I Olieslagers; Mathijs Groeneweg; Christina E M Voorter; Lotte Wieten
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 7.561

9.  qKAT: a high-throughput qPCR method for KIR gene copy number and haplotype determination.

Authors:  W Jiang; C Johnson; N Simecek; M R López-Álvarez; D Di; J Trowsdale; J A Traherne
Journal:  Genome Med       Date:  2016-09-29       Impact factor: 11.117

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.